JANET PIGGOTT: Open Payments
NPI 1922297860 · ALIQUIPPA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 14 payments from 11 companies in 2025. Trend: 2023 $2,295 · 2024 $2,660 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| ABBVIE INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: EVENITY, JARDIANCE, CAPVAXIVE, PROCLAIM, OTEZLA, CAPLYTA, REXULTI, SPRAVATO.
Industry payments across PA — which companies pay providers there.
